TSX:CPH (Cipher Pharmaceuticals)
About CPH
Cipher Pharmaceuticals, Inc. engages as a specialty pharmaceutical company, which have diversified portfolio of commercial and early to late-stage products. It acquires products that fulfill unmet medical needs, manages the required clinical development and regulatory approval process, and markets those products. Its products include dermatology, hospital acute care, and out-licensed products. The company was founded in 2000 and is headquartered in Mississauga, Canada.
Cipher Pharmaceuticals (TSX: CPH) Latest News
Dividend Stocks
Got $4,000? 4 Healthcare Stocks to Buy and Hold Forever
Stock Market
2 Growth Stocks Set to Skyrocket in 2025 and Beyond
Stocks for Beginners
This Healthcare Stock Could Be the Best Investment of the Decade
Dividend Stocks
1 Canadian Stock Ready to Start 2025 With a Bang